CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma
NCT06182735
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Carcinoma
Interventions
COMBINATION_PRODUCT:
Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells
Sponsor
Fudan University